Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company, is a clinical-stage company developing orexin receptor 2 (OX2R) agonists for narcolepsy and potentially other sleep-wake disorders. Its lead investigational candidate, cleminorexton, is being developed for narcolepsy type 1, narcolepsy type 2, and idiopathic hypersomnia. The company is headquartered in Boston, Massachusetts, and was recognized as a Great Place to Work in 2026. The Senior Director, Regulatory CMC provides strategic and operational leadership for Regulatory CMC activities across the company’s small molecule development programs. Reporting to the Executive Director, Regulatory CMC, this role leads Regulatory CMC initiatives, develops and executes global CMC regulatory strategies, partners with internal and external stakeholders, and oversees CMC regulatory submissions across the portfolio. The role supports programs from early development through regulatory submission, with required recent, hands-on leadership of late-stage development, NDA-enabling activities, and marketing application submissions. Strong expertise in outsourced development and manufacturing and the ability to drive regulatory readiness and execution in a fast-paced environment are important. The position is remote and based in the United States, with occasional travel. The anticipated wage is $175,500–$283,800. Full-time equivalent employees are eligible for a company bonus, subject in part to company and individual performance, and a comprehensive benefits program for eligible employees.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior